Sept 15 (Reuters) - Drug developer aTyr Pharma's (ATYR.O), opens new tab experimental drug failed to meet the main goal in a late-stage study for the treatment of a type of lung disease, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback